Information to investors

Inven2 wants to have a close dialogue with you as an investor and as someone who might have an interest in investing in and contributing to developing our active innovation projects. These are projects that we believe have the potential to become successful businesses

We receive 150–200 proposals for new inventions and commercialisation opportunities every year from researchers employed at the University of Oslo and the health trusts under the South-Eastern Norway Regional Health Authority. We proceed with around 30% of the proposals as active innovation projects in close cooperation with the inventors. Some inventions are obvious candidates for licencing to established industry, while others have the potential to become companies that develope products and services that can make an impact on the community at large.

Innovation projects that we believe are best developed through business start-ups need competent investors to join, maybe it is you?

Twice a year, we organise ‘Inven2Pitch’, where we present our most promising projects to investors and entrepreneurs. Here you can learn more about these projects, meet the researchers behind the inventions and Inven2’s employees who work to commercialise the invention.

Investment opportunities


Here is an overview of four of our most promising innovation projects at present. These are projects we consider to be suitable as business start-ups, and for which we are looking for investors.

Therapeutic regulation of WNT/YAP-signaling through a potent and specific tankyrase inhibitor

A class of novel WNT/YAP inhibitor compounds exhibiting high specificity for tankyrase and demonstrated proof of concept in mouse models for several cancer indications. Read More

AnaConDebt – Analysis of Contagious technical Debt

Technical debt in software development consists of sub-optimal design solutions that are beneficial in the short term, but create costly negative impact in the long run, e.g. costly maintenance changes and impossibility to evolve the system. Read More

High data-rate wireless communication for deep medical implants

A prototype system for wireless capsule endoscopy utilizing radio frequency backscatter communication is developed. Read More

Portfolio businesses

Portfolio businesses

Inven2 has a portfolio comprising 53 companies. We have established them either on our own or alongside investors and others. The point of departure for the companies are research results from innovative researchers. Together, the companies are worth around NOK 12.5 billion.